Time-to-first exacerbation, adherence, and medical costs among US patients receiving umeclidinium/vilanterol or tiotropium as initial maintenance therapy for chronic obstructive pulmonary disease: A retrospective cohort study

Định dạng: PDF / Số trang: 10

Nhắn tin với admin nếu không tải được